Atea Pharmaceuticals, Inc.
← Back to AVIR Overview

Atea Pharmaceuticals, Inc. (AVIR)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-1.55

Financial Fundamentals

AVIR • Quarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2019-03-31-34.90
2019-06-30-21.54
2019-09-30-98.76
2019-12-31-77.06
2020-03-31-89.95
2020-06-30-35.90
2020-09-30-34.11
2020-12-3141.76
2021-03-3141.51
2021-06-30288.72
2021-09-30-25.75
2021-12-311.59
2022-03-31-3.57
2022-06-30-4.72
2022-09-30-14.68
2022-12-31-2.91
2023-03-31-1.97
2023-06-30-2.77
2023-09-30-1.89
2023-12-31-1.62
2024-03-31-1.33
2024-06-30-1.75
2024-09-30-2.27
2024-12-31-2.11
2025-03-31-1.86
2025-06-30-2.03
2025-09-30-1.36
2025-12-31-1.55

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.